CD8A and hepatocellular carcinoma: In a meta-analysis of 12 clinical trials [26], it was concluded that TCM plus TACE compared with TACE alone improved immune responses against HCC in patients and increased the proportions of CD3+ and CD4+ T cells, as well as the CD4+/CD8+ T-cell ratio.